Pomona, New York — August 25, 2025 — NeuroLight, Inc., a neurotechnology company developing neuromodulation solutions for sleep and neurological health, today announced the appointment of Geoffrey Lawrence as Chief Financial Officer.
Geoffrey Lawrence is a seasoned financial executive with extensive experience leading companies in highly regulated industries, particularly therapeutic and medical product development and distribution. Most recently, Mr. Lawrence served as CFO of Claybourne Industries, a California-based therapeutic and medicinal products company, where he successfully led a VC-backed Series A funding round. Previously, he was CFO of C Quadrant, LLC, a botanical extracts startup that was acquired by publicly traded Lowell Farms. Earlier in his career, Mr. Lawrence served as CFO for multiple companies in the medical products sector, including Apex Solutions, Inc., an Oakland-based therapeutic products manufacturer that he helped take public, and Players Network, Inc., a Las Vegas-based public company focused on medical product manufacturing. From 2015 to 2017, Mr. Lawrence brought his financial expertise to the public sector as a senior appointee in the Nevada State Controller’s Office, where he oversaw statewide financial reporting operations.
“Geoffrey’s blend of operational finance and capital markets experience is exactly what NeuroLight needs as we scale,” said Alexander Poltorak, Founder and President of NeuroLight. “His track record in regulated industries and company-building will help us fund growth and execute our commercialization plan. We’re delighted to welcome him to the team.”
“I am pleased to join NeuroLight as the company heads into its next phase of growth. The patented technology incorporated into NeuroLight’s products is a game-changer that can revolutionize the sleep industry and beyond,” said Mr. Lawrence. “I couldn’t be more excited about the future of this company and the ways in which it could change the way we treat and, more importantly, prevent neurodegenerative diseases.”
NeuroLight’s flagship product, the NeuroMask™ smart sleep mask, uses proprietary sensory brain stimulation, combining precisely calibrated light and sound patterns to help induce and stabilize specific brain states—from deep sleep to peak performance states. The company is pursuing a staged go-to-market strategy across wellness and medical device pathways while building clinical evidence for therapeutic applications.